Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival
- PMID: 22271902
- PMCID: PMC3366655
- DOI: 10.3324/haematol.2011.054361
Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival
Abstract
While most myelodysplastic syndrome/acute myeloid leukemia cases are sporadic, rare familial cases occur and provide some insight into leukemogenesis. The most clearly defined familial cases result from inherited mutations in RUNX1 or CEBPA. Recently, novel germline mutations in GATA2 have been reported. We, therefore, investigated individuals from families with one or more first-degree relatives with myelodysplastic syndrome/acute myeloid leukemia with wild-type RUNX1 and CEBPA, for GATA2 mutations. Screening for other recurrent mutations was also performed. A GATA2 p.Thr354Met mutation was observed in a pedigree in which 2 first-degree cousins developed high-risk myelodys-plastic syndrome with monosomy 7. They were also observed to have acquired identical somatic ASXL1 mutations and both died despite stem cell transplantation. These findings confirm that germline GATA2 mutations predispose to familial myelodysplastic syndrome/acute myeloid leukemia, and that monosomy 7 and ASXL1 mutations may be recurrent secondary genetic abnormalities triggering overt malignancy in these families.
Figures


Similar articles
-
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.Blood. 2016 Mar 17;127(11):1387-97; quiz 1518. doi: 10.1182/blood-2015-09-669937. Epub 2015 Dec 23. Blood. 2016. PMID: 26702063
-
[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].Orv Hetil. 2016 Feb 21;157(8):283-9. doi: 10.1556/650.2016.30375. Orv Hetil. 2016. PMID: 26876264 Review. Hungarian.
-
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.Blood. 2015 Nov 26;126(22):2484-90. doi: 10.1182/blood-2015-04-641100. Epub 2015 Oct 22. Blood. 2015. PMID: 26492932 Free PMC article. Clinical Trial.
-
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.Nat Genet. 2011 Sep 4;43(10):1012-7. doi: 10.1038/ng.913. Nat Genet. 2011. PMID: 21892162 Free PMC article.
-
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).Blood. 2020 Jul 2;136(1):24-35. doi: 10.1182/blood.2019000937. Blood. 2020. PMID: 32430494 Free PMC article. Review.
Cited by
-
Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations.Haematologica. 2014 Feb;99(2):201-3. doi: 10.3324/haematol.2013.101303. Haematologica. 2014. PMID: 24497555 Free PMC article. No abstract available.
-
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.Blood. 2014 Feb 6;123(6):809-21. doi: 10.1182/blood-2013-07-515528. Epub 2013 Nov 13. Blood. 2014. PMID: 24227816 Free PMC article.
-
The evolution of cellular deficiency in GATA2 mutation.Blood. 2014 Feb 6;123(6):863-74. doi: 10.1182/blood-2013-07-517151. Epub 2013 Dec 17. Blood. 2014. PMID: 24345756 Free PMC article.
-
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.Nat Commun. 2020 Feb 25;11(1):1044. doi: 10.1038/s41467-020-14829-5. Nat Commun. 2020. PMID: 32098966 Free PMC article.
-
GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.Br J Haematol. 2022 Nov;199(4):482-495. doi: 10.1111/bjh.18330. Epub 2022 Jun 26. Br J Haematol. 2022. PMID: 35753998 Free PMC article. Review.
References
-
- Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood. 2002;99(4):1364–72. - PubMed
-
- Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23(2):166–75. - PubMed
-
- Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med. 2004;351(23):2403–7. - PubMed
-
- Scott HS, Hahn CN, Carmichael CL, Wilkins EJ, Chong CE, Brautigan PJ, Li XC, Stankovic M, Lin M. GATA2 is a new pre-disposition gene for familial myelodyplastic syndrome (MDS) and acute myeloid leukaemia (AML) ASH Annual Meeting Abstracts. 2010;116:21:LBA3.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical